ArticleRheumatology (Oxford, England)2023

A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients.

Joanna E Parkes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.